Hypoxia Promotes Drug Resistance in Osteosarcoma Cells Via Activating AMP-activated Protein Kinase (AMPK) Signaling

Overview

Journal J Bone Oncol

Publisher Elsevier

Date 2016 Mar 22

PMID 26998423

Citations 22

Authors

Changfu Zhao

Qiao Zhang

Tao Yu

Shudong Sun

Wenjun Wang

Guangyao Liu

Affiliations

Soon will be listed here.

Abstract

Purpose: Drug resistance has been recognized to be a major obstacle to the chemotherapy for osteosarcoma. And the potential importance of hypoxia as a target to reverse drug resistance in osteosarcoma has been indicated, though the mechanism underlining such role is not clarified. The present study aims to investigate the role of hypoxia in the drug resistance in osteosarcoma cells via activating AMP-activated protein kinase (AMPK) signaling.

Experimental Design: We investigated the promotion of the resistance to doxorubicin of osteosarcoma MG-63 and U2-os cells in vitro, and then determined the role of hypoxia-inducible factor-1 (HIF-1)α and HIF-1β, the activation and regulatory role of AMPK in the osteosarcoma U2-os cells which were treated with doxorubicin under hypoxia.

Results: It was demonstrated that hypoxia significantly reduced the sensitivity of MG-63 and U2-os cells to doxorubicin, indicating an inhibited viability reduction and a reduced apoptosis promotion. And such reduced sensitivity was not associated with HIF-1α, though it was promoted by hypoxia in U2-os cells. Interestingly, the AMPK signaling was significantly promoted by hypoxia in the doxorubicin-treated U2-os cells, with a marked upregulation of phosphorylated AMPK (Thr 172) and phosphorylated acetyl-CoA carboxylase (ACC) (Ser 79), which were sensitive to the AMPK activator, AICAR and the AMPK inhibitor, Compound C. Moreover, the promoted AMPK activity by AICAR or the downregulated AMPK activity by Compound C significantly reduced or promoted the sensitivity of U2-os cells to doxorubicin.

Conclusion: The present study confirmed the AMPK signaling activation in the doxorubicin-treated osteosarcoma cells, in response to hypoxia, and the chemical upregulation or downregulation of AMPK signaling reduced or increased the chemo-sensitivity of osteosarcoma U2-os cells in vitro. Our study implies that AMPK inhibition might be a effective strategy to sensitize osteocarcoma cells to chemotherapy.

Citing Articles

Polydatin-Induced Shift of Redox Balance and Its Anti-Cancer Impact on Human Osteosarcoma Cells.

Cimmino A, Gioia M, Clementi M, Faraoni I, Marini S, Ciaccio C Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852136 PMC: 11764470. DOI: 10.3390/cimb47010021.

Metformin sensitises osteosarcoma to chemotherapy <em>via</em> the IGF-1R/miR-610/FEN1 pathway.

Dong S, Xiao Y, Zhu Z, Ma X, Peng Z, Kang J Eur J Histochem. 2023; 67(2).

PMID: 37195011 PMC: 10230554. DOI: 10.4081/ejh.2023.3612.

Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer.

Peng B, Zhang S, Chan K, Zhong Z, Wang Y Molecules. 2023; 28(2).

PMID: 36677797 PMC: 9863744. DOI: 10.3390/molecules28020740.

Exploration of various roles of hypoxia genes in osteosarcoma.

Ma J, Guo Z, Yang X, Zhu Y Sci Rep. 2022; 12(1):18293.

PMID: 36316355 PMC: 9622735. DOI: 10.1038/s41598-022-17622-0.

Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality.

Yu L, Zhang J, Li Y Front Immunol. 2022; 13:871076.

PMID: 36311748 PMC: 9608329. DOI: 10.3389/fimmu.2022.871076.

References

Achison M, Hupp T . Hypoxia attenuates the p53 response to cellular damage. Oncogene. 2003; 22(22):3431-40. DOI: 10.1038/sj.onc.1206434. View

Hu Y, Jahangiri A, De Lay M, Aghi M . Hypoxia-induced tumor cell autophagy mediates resistance to anti-angiogenic therapy. Autophagy. 2012; 8(6):979-81. PMC: 3427265. DOI: 10.4161/auto.20232. View

Stiller C . International patterns of cancer incidence in adolescents. Cancer Treat Rev. 2007; 33(7):631-45. DOI: 10.1016/j.ctrv.2007.01.001. View

Hamacher-Brady A, Brady N, Gottlieb R . Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem. 2006; 281(40):29776-87. DOI: 10.1074/jbc.M603783200. View

Yamada N, Yamanegi K, Ohyama H, Hata M, Nakasho K, Futani H . Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner. Int J Oncol. 2012; 41(6):2005-12. DOI: 10.3892/ijo.2012.1630. View

Toyoda T, Hayashi T, Miyamoto L, Yonemitsu S, Nakano M, Tanaka S . Possible involvement of the alpha1 isoform of 5'AMP-activated protein kinase in oxidative stress-stimulated glucose transport in skeletal muscle. Am J Physiol Endocrinol Metab. 2004; 287(1):E166-73. DOI: 10.1152/ajpendo.00487.2003. View

Wittig J, Bickels J, Priebat D, Jelinek J, Shmookler B, Malawer M . Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician. 2002; 65(6):1123-32. View

Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T . Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res. 2007; 100(6):914-22. DOI: 10.1161/01.RES.0000261924.76669.36. View

Chhipa R, Wu Y, Ip C . AMPK-mediated autophagy is a survival mechanism in androgen-dependent prostate cancer cells subjected to androgen deprivation and hypoxia. Cell Signal. 2011; 23(9):1466-72. PMC: 3115439. DOI: 10.1016/j.cellsig.2011.04.008. View

10.

Porter A, Janicke R . Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999; 6(2):99-104. DOI: 10.1038/sj.cdd.4400476. View

11.

Song X, Liu X, Chi W, Liu Y, Wei L, Wang X . Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Cancer Chemother Pharmacol. 2006; 58(6):776-84. DOI: 10.1007/s00280-006-0224-7. View

12.

Grahame Hardie D, Ross F, Hawley S . AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012; 13(4):251-62. PMC: 5726489. DOI: 10.1038/nrm3311. View

13.

Todde V, Veenhuis M, van der Klei I . Autophagy: principles and significance in health and disease. Biochim Biophys Acta. 2008; 1792(1):3-13. DOI: 10.1016/j.bbadis.2008.10.016. View

14.

Semenza G . Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE. 2007; 2007(407):cm8. DOI: 10.1126/stke.4072007cm8. View

15.

Woods A, Dickerson K, Heath R, Hong S, Momcilovic M, Johnstone S . Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005; 2(1):21-33. DOI: 10.1016/j.cmet.2005.06.005. View

16.

Shen Y, Yang J, Zhao J, Xiao C, Xu C, Xiang Y . The switch from ER stress-induced apoptosis to autophagy via ROS-mediated JNK/p62 signals: A survival mechanism in methotrexate-resistant choriocarcinoma cells. Exp Cell Res. 2015; 334(2):207-18. DOI: 10.1016/j.yexcr.2015.04.010. View

17.

Chen Y, McMillan-Ward E, Kong J, Israels S, Gibson S . Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species. J Cell Sci. 2007; 120(Pt 23):4155-66. DOI: 10.1242/jcs.011163. View

18.

Erler J, Cawthorne C, Williams K, Koritzinsky M, Wouters B, Wilson C . Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Mol Cell Biol. 2004; 24(7):2875-89. PMC: 371100. DOI: 10.1128/MCB.24.7.2875-2889.2004. View

19.

Emerling B, Weinberg F, Snyder C, Burgess Z, Mutlu G, Viollet B . Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio. Free Radic Biol Med. 2009; 46(10):1386-91. PMC: 3326346. DOI: 10.1016/j.freeradbiomed.2009.02.019. View

20.

Greer E, Dowlatshahi D, Banko M, Villen J, Hoang K, Blanchard D . An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr Biol. 2007; 17(19):1646-56. PMC: 2185793. DOI: 10.1016/j.cub.2007.08.047. View